Envestnet Asset Management Inc. Decreases Stake in Simulations Plus, Inc. (NASDAQ:SLP)

Share on StockTwits

Envestnet Asset Management Inc. lowered its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 11.2% in the third quarter, Holdings Channel reports. The firm owned 12,819 shares of the technology company’s stock after selling 1,617 shares during the period. Envestnet Asset Management Inc.’s holdings in Simulations Plus were worth $445,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of SLP. Neuburgh Advisers LLC grew its holdings in shares of Simulations Plus by 419.4% during the 2nd quarter. Neuburgh Advisers LLC now owns 2,576 shares of the technology company’s stock worth $74,000 after purchasing an additional 2,080 shares during the period. Glen Harbor Capital Management LLC grew its holdings in shares of Simulations Plus by 419.4% during the 2nd quarter. Glen Harbor Capital Management LLC now owns 3,542 shares of the technology company’s stock worth $101,000 after purchasing an additional 2,860 shares during the period. Elkfork Partners LLC grew its holdings in shares of Simulations Plus by 419.4% during the 2nd quarter. Elkfork Partners LLC now owns 4,508 shares of the technology company’s stock worth $129,000 after purchasing an additional 3,640 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in shares of Simulations Plus by 5.9% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 4,783 shares of the technology company’s stock worth $137,000 after purchasing an additional 265 shares during the period. Finally, Meadow Creek Investment Management LLC grew its holdings in shares of Simulations Plus by 419.4% during the 2nd quarter. Meadow Creek Investment Management LLC now owns 5,474 shares of the technology company’s stock worth $156,000 after purchasing an additional 4,420 shares during the period. Institutional investors and hedge funds own 43.27% of the company’s stock.

A number of brokerages have recently issued reports on SLP. Liberum Capital reiterated a “buy” rating on shares of Simulations Plus in a report on Tuesday, October 22nd. BidaskClub cut Simulations Plus from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. Zacks Investment Research upgraded Simulations Plus from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a report on Wednesday, October 30th. Finally, ValuEngine cut Simulations Plus from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $38.00.

In other Simulations Plus news, Director Walter S. Woltosz sold 24,000 shares of the company’s stock in a transaction that occurred on Sunday, October 27th. The stock was sold at an average price of $33.45, for a total value of $802,800.00. Following the completion of the transaction, the director now owns 5,063,918 shares in the company, valued at approximately $169,388,057.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last 90 days, insiders sold 72,000 shares of company stock valued at $2,532,720. 31.57% of the stock is owned by company insiders.

NASDAQ SLP opened at $32.83 on Thursday. The stock has a market cap of $582.40 million, a PE ratio of 65.66 and a beta of -0.34. Simulations Plus, Inc. has a fifty-two week low of $17.18 and a fifty-two week high of $41.95. The business has a 50 day moving average price of $34.18 and a two-hundred day moving average price of $31.70.

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Friday, October 25th were issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date was Thursday, October 24th. Simulations Plus’s dividend payout ratio is presently 48.00%.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Recommended Story: How to Calculate Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Short Interest in Ovid Therapeutics Inc  Declines By 16.4%
Short Interest in Ovid Therapeutics Inc Declines By 16.4%
NI Holdings Inc  Short Interest Down 12.2% in November
NI Holdings Inc Short Interest Down 12.2% in November
NewLink Genetics Corp  Short Interest Update
NewLink Genetics Corp Short Interest Update
Neurocrine Biosciences, Inc.  Short Interest Update
Neurocrine Biosciences, Inc. Short Interest Update
Nasdaq Inc  Short Interest Up 16.8% in November
Nasdaq Inc Short Interest Up 16.8% in November
Short Interest in MACOM Technology Solutions Holdings Inc  Drops By 7.8%
Short Interest in MACOM Technology Solutions Holdings Inc Drops By 7.8%


© 2006-2019 Ticker Report